Searchable abstracts of presentations at key conferences in endocrinology

ea0014p383 | (1) | ECE2007

Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patients

Faggiano Antongiulio , Di Somma Carolina , Milone Francesco , Ramundo Valeria , Lombardi Gaetano , Coloa Annamaria , Spiezia Stefano

Background: Nodular goiter is one of the commonest endocrinopathy. Its incidence increases with age accounting for more than 50% of subjects older than 60 years. Elderly subjects more frequently suffer from pressure symptoms. Loco-regional treatments, like laser photocoagulation and percutaneous ethanol injection, are a potentially useful tool to treat TNs but their efficacy is still debated. Radiofrequency thermal ablation (RTA) has been applied to several benign and malignan...

ea0014p645 | (1) | ECE2007

Effect of age and testosterone on sleep related erections

Granata Antonio R M , Rochira Vincenzo , Madeo Bruno , Pugni Valeria , Zirilli Lucia , Carani Cesare

Introduction: In order to study the effect of age and testosterone on sleep related erections, we enrolled 209 men (122: age 30–49 years; 87: age over 50 years), including mild and severe hypogonadal subjects (129) and eugonadal subjects (80).Subjects and methods: The subjects were assigned to four groups, according to their testosterone serum levels. All the subjects underwent nocturnal penile tumescence and rigidity monitoring (NPTRM). The followi...

ea0056oc12.3 | Novel aspects of puberty development and Cushing's disease | ECE2018

Evaluation of genetic predisposition in severe and mild phenotypes of isolated hypogonadotropic hypogonadism

Cangiano Biagio , Duminuco Paolo , Vezzoli Valeria , Guizzardi Fabiana , Persani Luca , Bonomi Marco

Introduction: Isolated hypogonadotropic hypogonadism (IHH) often occurs in the pre-pubertal period but it can also manifest in post-puberal age. Recent position statements and guidelines differentiate between a ‘true’ hypogonadotropic hypogonadism, intended as congenital or acquired organic defect (characterized by frankly pathological total Testoterone values, TTe <3.5 nmol/l), and a ‘false’ or functional hypogonadism, associated to older age and comor...

ea0056gp144 | Neuroendocrinology | ECE2018

Genetics of binge-eating disorder (BED): a pilot study

Cacciatore Chiara , Vezzoli Valeria , Duminuco Paolo , Scacchi Massimo , Mai Stefania , Polli Nicoletta , Persani Luca

Binge-eating disorder (BED) is characterized by recurrent (≥1 per week for 3 months), brief (≤2 h), psychologically distressing binge-eating episodes during which patients sense a lack of control and consume larger amounts of food than most people would under similar circumstances. The prevalence of BED is estimated to be between 2% and 3.5% and majority of individuals with BED are either overweight or obese. Most of the genetic research about eating disorders (ED)...

ea0073pep6.1 | Presented ePosters 6: Calcium and Bone | ECE2021

Comparative evaluation of bone turnover markers in diabetic rats treated with sitagliptin, canagliflozin, empagliflozin

Timkina Natalya , Simanenkova Anna , Shpilevaya Oksana , Khalzova Aleksandra , Shimshilashvili Anzhelika , Timofeeva Valeria , Vlasov Timur , Karonova Tatiana

Background and aimsAlthough bone fracture risk increases in DM, bone mineral density does not completely reflect bone fragility. It is important to explore other methods of osteoporotic fracture risk evaluation. Nowadays bone turnover markers (BTM) investigation is not widely used in clinical practice. On the other hand, the action of some glucose-lowering drugs on bone remodeling is not completely explored. The aim of this study was to investigate and t...

ea0075m08 | Metabolic Bone | EYES2021

Safety and efficacy of PTH 1-34 and 1-84 therapy in chronic hypoparathyroidism: a meta-analysis of prospective trials

Hasenmajer Valeria , Puliani Giulia , Sada Valentina , Tarantino Chiara , Lenzi Andrea , Isidori Andrea

Introduction: Hypoparathyroidism is the only endocrine deficiency for which replacement therapy with the missing hormone is not part of the clinical practice. High quality evidence on the use of PTH 1-34 or PTH 1-84 in hypoparathyroidism is missing.Objective: We aim to evaluate the efficacy and safety of PTH 1-34 and PTH 1-84, and to compare the two treatments when possible.Methods: We searched databases up to March 2021 for random...

ea0092op-02-02 | Oral Session 2: Thyroid hormone action in the brain | ETA2023

Development of an image-based method for spatial registration of T3-induced changes in cell types and gene expression in human cerebral organoids

Bresser Audrey , Obermayer-Wasserscheid Benedikt , Megges Matthias , Fernandez-Vallone Valeria , Stachelscheid Harald , Kuhnen Peter , Opitz Robert

Thyroid hormone (TH) signaling is essential for nervous system development. The clinical relevance of this simple statement is underscored by the severe neurological phenotypes resulting from global TH deficiency or perturbed local TH signaling during fetal development. A major aim of our research is to better understand the local action of TH during early human cortex development using cerebral organoids derived from human induced pluripotent stem cells (hiPSC) as a model sys...

ea0092ps1-06-04 | Thyroid Cancer clinical 1 | ETA2023

Predictive factors for central neck compartment lymphnodes metastases’ in sporadic medullary thyroid cancer patients

Cappagli Virginia , Matrone Antonio , Piaggi Paolo , Bottici Valeria , Agate Laura , Molinaro Eleonora , Torregrossa Liborio , Elisei Rossella

Introduction: Total thyroidectomy (TT) plus central neck compartment (CC) lymphnode dissection is still the recommended initial gold standard treatment for medullary thyroid cancer (MTC), even in the absence of a pre-surgical positive neck US evidence of lymphnode metastases. Considering the risk of surgical complications of this prophylactic surgery and the low rate of histologic finding of CC lymphnode metastases, a more tailored lymphnode’ surgery should be proposed. A...

ea0092ps3-27-02 | Thyroid Cancer clinical 3 | ETA2023

Central (N1A) and latero-cervical (N1B) lymph nodes metastases in sporadic medullary thyroid carcinoma patients: clinical impact on disease specific and recurrence free survival

Matrone Antonio , Prete Alessandro , Gambale Carla , Cappagli Virginia , Bottici Valeria , Materazzi Gabriele , Torregrossa Liborio , Elisei Rossella

Background: Distant metastases at diagnosis is the worst prognostic factor for disease specific survival (DSS) in sporadic medullary thyroid carcinoma (MTC). Also, lymph node metastases are negative prognostic factors both for DSS and recurrence free survival (RFS). The question whether central (N1a) and latero-cervical compartment lymph nodes metastasis (N1b), separately evaluated, can have a different impact on DSS and RFS remains to be clarified.Patie...

ea0092ps3-28-02 | Translational 2 | ETA2023

Hypothesizing a role of ret hyperactivation on weight control in patients with type 2A multiple endocrine neoplasia (MEN2A)

Prete Alessandro , Gambale Carla , Piaggi Paolo , Romei Cristina , Cappagli Virginia , Bottici Valeria , Elisei Rossella , Matrone Antonio

Introduction: RET gene is responsible for various human cancers and is mutated and hyperactivated in nearly 100% of familial (germline mutation) and in about 60% of sporadic (somatic mutation) MTC cases. Moreover, RET gene play a role in several physiologic and pathologic conditions. Very recently, the hyperfunction of RET was found to be a key process in weight loss. The hypothesis is that in a peculiar population in which RET gene is mutated and constitutively activated from...